Menstrual Phase and Postoperative Pain

NCT02137135 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2014-05-13

No results posted yet for this study

Summary

Fluctuations of female sex hormones during the menstrual cycle influence pain perception. Endogenous pain is pronounced in the follicular phase of the menstrual cycle. The investigators tested the primary hypothesis that the women having surgery during their follicular phase have more acute pain and require more opioids than those in the luteal phase, and secondarily the investigators tested that women who have surgery during their follicular phase have more incisional pain at 3 month postoperatively.

Conditions

  • Acute Postoperative Pain
  • Chronic Postoperative Pain

Interventions

OTHER

HAD scale

The anxiety/depression scale (HAD) was used to assess anxiety and depression.

OTHER

The SF 12 test

The SF 12 test (SHORT FORM 12) was used to evaluate quality of life.

OTHER

Visual analogue score

Visual analogue score vas used to evaluate pain.

Sponsors & Collaborators

  • Aydin Adnan Menderes University

    lead OTHER

Principal Investigators

  • Betul Kozanhan, Specialist Doctor · Konya Education and Research Hospital, Anesthesiology and Reanimation Department, Konya; Turkey

  • Ayse Ilksen Egilmez, Specialist Doctor · Konya Education and Research Hospital, Anesthesiology and Reanimation Department, Konya; Turkey

  • Aykut Soyder, Assistant Professor · Adnan Menderes University Medical Faculty, General Surgery Department, Aydin; Turkey

  • Fabrizio Galimberti, Medical Student · Cleveland ClinicLernerCollege of Medicine, Cleveland, Ohio

  • Daniel I. Sessler, Professor and Ch · Department of Outcomes Research, Cleveland Clinic

  • Alparslan Turan, Associate Professor · Associate Professor of Anesthesiology, Department of Outcomes Research, Cleveland Clinic

  • Osman Nuri Aydın, Professor · Adnan Menderes University Medical Faculty, Anesthesiology and Reanimation Department, Aydin; Turkey

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02137135 on ClinicalTrials.gov